We are live on ! Find out more
DARE icon

Dare Bioscience

35 hedge funds and large institutions have $2.04M invested in Dare Bioscience in 2023 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 11 increasing their positions, 4 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

175% more repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 4

150% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 4

17% more funds holding

Funds holding: 30 → 35 (+5)

7.94% less ownership

Funds ownership: 14.64% → 6.7% (-7.9%)

95% less capital inflows, than outflows

Capital inflows: $158K | Capital outflows: $3.08M

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
35
Holders Change
+5
Holders Change %
+16.67%
% of All Funds
0.51%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
10
Increased
11
Reduced
4
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

DARE Hedge Fund Activity: Q4 2023 in Review

35 of the 6,880 institutional investors tracked by Wall St. Rank reported a position in Dare Bioscience (DARE) for Q4 2023, worth a combined $2.04M — down 66% from $5.97M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new DARE positions and 4 closed out — a net gain of 6 holders — while 11 added to existing stakes and 4 trimmed.

The largest buyer was Geode Capital Management, adding an estimated $58.3K. The largest seller was Armistice Capital, exiting entirely with an estimated $2.99M sold.

  • 35 institutional investors held Dare Bioscience (DARE) as of Q4 2023, up from 30 in Q3 2023.
  • Funds reported $2.04M of Dare Bioscience stock for Q4 2023, down 66% quarter-over-quarter.
  • 10 funds opened new Dare Bioscience positions in Q4 2023 and 4 closed out, a net change of +6 holders.
  • The largest Dare Bioscience buyer in Q4 2023 was Geode Capital Management, an estimated $58.3K added.
  • The largest Dare Bioscience seller in Q4 2023 was Armistice Capital, an estimated $2.99M sold.

Based on aggregated 13F filings for Q4 2023.